Holdings of Virtus Biotech Clinical Trials Etf
ETFis Series Trust I · Original filing · Compare with another fund · Report an error
- Net assets
- 46.4M $ including 46.3M $ in equities, 99.8 %
- Positions
- 131 in 9 countries
- Top ten
- 11.8 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | ArriVent Biopharma Inc | 10,177 | 303.5K $ | 0.65 % |
| 102 | Celcuity Inc | 3,510 | 303.2K $ | 0.65 % |
| 103 | Stoke Therapeutics Inc | 10,423 | 300.8K $ | 0.65 % |
| 104 | Septerna Inc | 8,646 | 297.9K $ | 0.64 % |
| 105 | BICYCLE THERAPEUTICS PLC | 76,743 | 296.2K $ | 0.64 % |
| 106 | Recursion Pharmaceuticals Inc | 98,670 | 296K $ | 0.64 % |
| 107 | AnaptysBio Inc | 5,543 | 295.8K $ | 0.64 % |
| 108 | Lexeo Therapeutics Inc | 71,124 | 293.7K $ | 0.63 % |
| 109 | Compass Therapeutics Inc | 153,110 | 292.4K $ | 0.63 % |
| 110 | EyePoint Inc | 23,853 | 292.2K $ | 0.63 % |
| 111 | COMPASS PATHWAYS PLC | 25,731 | 292K $ | 0.63 % |
| 112 | ProKidney Corp | 189,520 | 291.9K $ | 0.63 % |
| 113 | WAVE LIFE SCIENCES LTD | 52,951 | 291.8K $ | 0.63 % |
| 114 | VERA THERAPEUTICS INC | 9,072 | 291.2K $ | 0.63 % |
| 115 | Summit Therapeutics Inc | 22,185 | 288.8K $ | 0.62 % |
| 116 | Tectonic Therapeutic Inc | 10,265 | 287.7K $ | 0.62 % |
| 117 | IMMATICS NV | 33,135 | 286.9K $ | 0.62 % |
| 118 | NEWAMSTERDAM PHARMA COMPANY NV | 10,224 | 284.1K $ | 0.61 % |
| 119 | Monte Rosa Therapeutics Inc | 17,045 | 281.6K $ | 0.61 % |
| 120 | CABALETTA BIO INC | 103,259 | 276.7K $ | 0.60 % |
| 121 | Inhibrx Biosciences Inc | 3,371 | 276.6K $ | 0.60 % |
| 122 | Intellia Therapeutics Inc | 25,666 | 274.1K $ | 0.59 % |
| 123 | Beam Therapeutics Inc | 10,708 | 273.3K $ | 0.59 % |
| 124 | Tango Therapeutics Inc | 10,046 | 273.1K $ | 0.59 % |
| 125 | CRESCENT BIOPHARMA INC | 17,344 | 251K $ | 0.54 % |
| 126 | Relmada Therapeutics Inc | 46,738 | 248.2K $ | 0.54 % |
| 127 | Invivyd Inc | 403,655 | 216K $ | 0.47 % |
| 128 | Evommune Inc | 15,674 | 176.3K $ | 0.38 % |
| 129 | BioAge Labs Inc | 17,229 | 155.8K $ | 0.34 % |
| 130 | MAPLIGHT THERAPEUTICS INC | 11,201 | 145.8K $ | 0.31 % |
| 131 | Capricor Therapeutics Inc | 12,047 | 46.4K $ | 0.10 % |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 86.5 %
- Cayman Islands 4.0 %
- Netherlands 3.0 %
- Ireland 1.6 %
- Canada 1.5 %
- United Kingdom 1.3 %
- British Virgin Islands 0.8 %
- Switzerland 0.7 %
- Singapore 0.6 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 113 | 40.1M $ | 86.48 % |
| 2 | Cayman Islands | 5 | 1.9M $ | 4.04 % |
| 3 | Netherlands | 4 | 1.4M $ | 3.01 % |
| 4 | Ireland | 2 | 719K $ | 1.55 % |
| 5 | Canada | 2 | 712.6K $ | 1.54 % |
| 6 | United Kingdom | 2 | 588.3K $ | 1.27 % |
| 7 | British Virgin Islands | 1 | 372K $ | 0.80 % |
| 8 | Switzerland | 1 | 317K $ | 0.68 % |
| 9 | Singapore | 1 | 291.8K $ | 0.63 % |
Cite this page
Titelia. "Holdings of Virtus Biotech Clinical Trials Etf". https://titelia.com/en/funds/S000047353